StockData
Nexalin Technology, Inc. logo

Nexalin Technology, Inc. (NXL) stock

NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.44−0.06 (-4.00%)

Close on Nov 18, 2026Market cap $31.73MP/E –Yield –

Earnings

Nexalin Technology's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Nexalin Technology's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Nexalin Technology has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Nexalin Technology puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Nexalin Technology filed with the SEC as exhibits to Form 8-K or 6-K

  1. Update
  2. Update
  3. News
  4. Update
  5. Update
  6. News
  7. News
  8. News
  9. News
  10. News
  11. News
  12. News
  13. News
  14. News
  15. News

See a number that looks wrong?